Implementation and operational research: The impact of option B+ on the antenatal PMTCT cascade in Lilongwe, Malawi

Maria H. Kim, Saeed Ahmed, Mina C. Hosseinipour, Thomas P. Giordano, Elizabeth Y. Chiao, Xiaoying Yu, Chi Nguyen, Frank Chimbwandira, Peter N. Kazembe, Elaine J. Abrams

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Objective: In 2011, Malawi implemented Option B+ (B+), lifelong antiretroviral therapy (ART) for pregnant and breastfeeding women. We aimed to describe changes in service uptake and outcomes along the antenatal prevention of mother-to-child transmission (PMTCT) cascade post-B+ implementation. Design: Pre/post study using routinely collected program data from 2 large Lilongwe-based health centers. Methods: We compared the testing of HIV-infected pregnant women at antenatal care, enrollment into PMTCT services, receipt of ART, and 6-month ART outcomes pre-B+ (October 2009-March 2011) and post-B+ (October 2011-March 2013). Results: A total of 13,926 (pre) and 14,532 (post) women presented to antenatal care. Post-B+, a smaller proportion were HIV-tested (99.3% vs. 87.7% post-B+; P < 0.0001). There were 1654 (pre) and 1535 (post) HIV-infected women identified, with a larger proportion already known to be HIV-infected (18.1% vs. 41.2% post-B+; P < 0.0001) and on ART post-B+ (18.7% vs. 30.2% post-B+; P < 0.0001). A significantly greater proportion enrolled into the PMTCT program (68.3% vs. 92.6% post-B+; P < 0.0001) and was retained through delivery post-B+ (51.1% vs. 65% post-B+; P < 0.0001). Among those not on ART at enrollment, there was no change in the proportion newly initiating ART/antiretrovirals (79% vs. 81.9% post-B+; P 0.11), although median days to initiation of ART decreased [48 days (19, 130) vs. 0 days (0, 15.5) post-B+; P < 0.0001]. Among those newly initiating ART, a smaller proportion was alive on ART 6 months after initiation (89.3% vs. 78.8% post-B+; P 0.0004). Conclusions: Although several improvements in PMTCT program performance were noted with implementation of B+, challenges remain at several critical steps along the cascade requiring innovative solutions to ensure an AIDS-free generation.

Original languageEnglish (US)
Pages (from-to)e77-e83
JournalJournal of Acquired Immune Deficiency Syndromes
Volume68
Issue number5
DOIs
StatePublished - Apr 15 2015
Externally publishedYes

Fingerprint

Malawi
Mothers
Research
HIV
Prenatal Care
Therapeutics
Pregnant Women
Breast Feeding
Acquired Immunodeficiency Syndrome

Keywords

  • Africa
  • HIV
  • Malawi
  • Option B+
  • PMTCT
  • retention

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Implementation and operational research : The impact of option B+ on the antenatal PMTCT cascade in Lilongwe, Malawi. / Kim, Maria H.; Ahmed, Saeed; Hosseinipour, Mina C.; Giordano, Thomas P.; Chiao, Elizabeth Y.; Yu, Xiaoying; Nguyen, Chi; Chimbwandira, Frank; Kazembe, Peter N.; Abrams, Elaine J.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 68, No. 5, 15.04.2015, p. e77-e83.

Research output: Contribution to journalArticle

Kim, MH, Ahmed, S, Hosseinipour, MC, Giordano, TP, Chiao, EY, Yu, X, Nguyen, C, Chimbwandira, F, Kazembe, PN & Abrams, EJ 2015, 'Implementation and operational research: The impact of option B+ on the antenatal PMTCT cascade in Lilongwe, Malawi', Journal of Acquired Immune Deficiency Syndromes, vol. 68, no. 5, pp. e77-e83. https://doi.org/10.1097/QAI.0000000000000517
Kim, Maria H. ; Ahmed, Saeed ; Hosseinipour, Mina C. ; Giordano, Thomas P. ; Chiao, Elizabeth Y. ; Yu, Xiaoying ; Nguyen, Chi ; Chimbwandira, Frank ; Kazembe, Peter N. ; Abrams, Elaine J. / Implementation and operational research : The impact of option B+ on the antenatal PMTCT cascade in Lilongwe, Malawi. In: Journal of Acquired Immune Deficiency Syndromes. 2015 ; Vol. 68, No. 5. pp. e77-e83.
@article{3147991e4ef440dc942c08518ddbd4f5,
title = "Implementation and operational research: The impact of option B+ on the antenatal PMTCT cascade in Lilongwe, Malawi",
abstract = "Objective: In 2011, Malawi implemented Option B+ (B+), lifelong antiretroviral therapy (ART) for pregnant and breastfeeding women. We aimed to describe changes in service uptake and outcomes along the antenatal prevention of mother-to-child transmission (PMTCT) cascade post-B+ implementation. Design: Pre/post study using routinely collected program data from 2 large Lilongwe-based health centers. Methods: We compared the testing of HIV-infected pregnant women at antenatal care, enrollment into PMTCT services, receipt of ART, and 6-month ART outcomes pre-B+ (October 2009-March 2011) and post-B+ (October 2011-March 2013). Results: A total of 13,926 (pre) and 14,532 (post) women presented to antenatal care. Post-B+, a smaller proportion were HIV-tested (99.3{\%} vs. 87.7{\%} post-B+; P < 0.0001). There were 1654 (pre) and 1535 (post) HIV-infected women identified, with a larger proportion already known to be HIV-infected (18.1{\%} vs. 41.2{\%} post-B+; P < 0.0001) and on ART post-B+ (18.7{\%} vs. 30.2{\%} post-B+; P < 0.0001). A significantly greater proportion enrolled into the PMTCT program (68.3{\%} vs. 92.6{\%} post-B+; P < 0.0001) and was retained through delivery post-B+ (51.1{\%} vs. 65{\%} post-B+; P < 0.0001). Among those not on ART at enrollment, there was no change in the proportion newly initiating ART/antiretrovirals (79{\%} vs. 81.9{\%} post-B+; P 0.11), although median days to initiation of ART decreased [48 days (19, 130) vs. 0 days (0, 15.5) post-B+; P < 0.0001]. Among those newly initiating ART, a smaller proportion was alive on ART 6 months after initiation (89.3{\%} vs. 78.8{\%} post-B+; P 0.0004). Conclusions: Although several improvements in PMTCT program performance were noted with implementation of B+, challenges remain at several critical steps along the cascade requiring innovative solutions to ensure an AIDS-free generation.",
keywords = "Africa, HIV, Malawi, Option B+, PMTCT, retention",
author = "Kim, {Maria H.} and Saeed Ahmed and Hosseinipour, {Mina C.} and Giordano, {Thomas P.} and Chiao, {Elizabeth Y.} and Xiaoying Yu and Chi Nguyen and Frank Chimbwandira and Kazembe, {Peter N.} and Abrams, {Elaine J.}",
year = "2015",
month = "4",
day = "15",
doi = "10.1097/QAI.0000000000000517",
language = "English (US)",
volume = "68",
pages = "e77--e83",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Implementation and operational research

T2 - The impact of option B+ on the antenatal PMTCT cascade in Lilongwe, Malawi

AU - Kim, Maria H.

AU - Ahmed, Saeed

AU - Hosseinipour, Mina C.

AU - Giordano, Thomas P.

AU - Chiao, Elizabeth Y.

AU - Yu, Xiaoying

AU - Nguyen, Chi

AU - Chimbwandira, Frank

AU - Kazembe, Peter N.

AU - Abrams, Elaine J.

PY - 2015/4/15

Y1 - 2015/4/15

N2 - Objective: In 2011, Malawi implemented Option B+ (B+), lifelong antiretroviral therapy (ART) for pregnant and breastfeeding women. We aimed to describe changes in service uptake and outcomes along the antenatal prevention of mother-to-child transmission (PMTCT) cascade post-B+ implementation. Design: Pre/post study using routinely collected program data from 2 large Lilongwe-based health centers. Methods: We compared the testing of HIV-infected pregnant women at antenatal care, enrollment into PMTCT services, receipt of ART, and 6-month ART outcomes pre-B+ (October 2009-March 2011) and post-B+ (October 2011-March 2013). Results: A total of 13,926 (pre) and 14,532 (post) women presented to antenatal care. Post-B+, a smaller proportion were HIV-tested (99.3% vs. 87.7% post-B+; P < 0.0001). There were 1654 (pre) and 1535 (post) HIV-infected women identified, with a larger proportion already known to be HIV-infected (18.1% vs. 41.2% post-B+; P < 0.0001) and on ART post-B+ (18.7% vs. 30.2% post-B+; P < 0.0001). A significantly greater proportion enrolled into the PMTCT program (68.3% vs. 92.6% post-B+; P < 0.0001) and was retained through delivery post-B+ (51.1% vs. 65% post-B+; P < 0.0001). Among those not on ART at enrollment, there was no change in the proportion newly initiating ART/antiretrovirals (79% vs. 81.9% post-B+; P 0.11), although median days to initiation of ART decreased [48 days (19, 130) vs. 0 days (0, 15.5) post-B+; P < 0.0001]. Among those newly initiating ART, a smaller proportion was alive on ART 6 months after initiation (89.3% vs. 78.8% post-B+; P 0.0004). Conclusions: Although several improvements in PMTCT program performance were noted with implementation of B+, challenges remain at several critical steps along the cascade requiring innovative solutions to ensure an AIDS-free generation.

AB - Objective: In 2011, Malawi implemented Option B+ (B+), lifelong antiretroviral therapy (ART) for pregnant and breastfeeding women. We aimed to describe changes in service uptake and outcomes along the antenatal prevention of mother-to-child transmission (PMTCT) cascade post-B+ implementation. Design: Pre/post study using routinely collected program data from 2 large Lilongwe-based health centers. Methods: We compared the testing of HIV-infected pregnant women at antenatal care, enrollment into PMTCT services, receipt of ART, and 6-month ART outcomes pre-B+ (October 2009-March 2011) and post-B+ (October 2011-March 2013). Results: A total of 13,926 (pre) and 14,532 (post) women presented to antenatal care. Post-B+, a smaller proportion were HIV-tested (99.3% vs. 87.7% post-B+; P < 0.0001). There were 1654 (pre) and 1535 (post) HIV-infected women identified, with a larger proportion already known to be HIV-infected (18.1% vs. 41.2% post-B+; P < 0.0001) and on ART post-B+ (18.7% vs. 30.2% post-B+; P < 0.0001). A significantly greater proportion enrolled into the PMTCT program (68.3% vs. 92.6% post-B+; P < 0.0001) and was retained through delivery post-B+ (51.1% vs. 65% post-B+; P < 0.0001). Among those not on ART at enrollment, there was no change in the proportion newly initiating ART/antiretrovirals (79% vs. 81.9% post-B+; P 0.11), although median days to initiation of ART decreased [48 days (19, 130) vs. 0 days (0, 15.5) post-B+; P < 0.0001]. Among those newly initiating ART, a smaller proportion was alive on ART 6 months after initiation (89.3% vs. 78.8% post-B+; P 0.0004). Conclusions: Although several improvements in PMTCT program performance were noted with implementation of B+, challenges remain at several critical steps along the cascade requiring innovative solutions to ensure an AIDS-free generation.

KW - Africa

KW - HIV

KW - Malawi

KW - Option B+

KW - PMTCT

KW - retention

UR - http://www.scopus.com/inward/record.url?scp=84925282168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925282168&partnerID=8YFLogxK

U2 - 10.1097/QAI.0000000000000517

DO - 10.1097/QAI.0000000000000517

M3 - Article

C2 - 25585302

AN - SCOPUS:84925282168

VL - 68

SP - e77-e83

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 5

ER -